首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >The beta 1 isoform of protein kinase C mediates the protective effects of epidermal growth factor on the dynamic assembly of F-actin cytoskeleton and normalization of calcium homeostasis in human colonic cells.
【24h】

The beta 1 isoform of protein kinase C mediates the protective effects of epidermal growth factor on the dynamic assembly of F-actin cytoskeleton and normalization of calcium homeostasis in human colonic cells.

机译:蛋白激酶C的beta 1亚型介导表皮生长因子对F-肌动蛋白细胞骨架的动态组装和人结肠细胞钙稳态的正常化的保护作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Using intestinal monolayers, we showed that F-actin cytoskeletal stabilization and Ca(2+) normalization contribute to epidermal growth factor (EGF)-mediated protection against oxidant injury. However, the intracellular mediator responsible for these protective effects remains unknown. Since the protein kinase C-beta1 (PKC-beta1) isoform is abundant in our naive (N) cells, we hypothesized that PKC-beta1 is essential to EGF protection. Monolayers of N Caco-2 cells were exposed to H(2)O(2) +/- EGF, PKC, or Ca(2+) modulators. Other cells were transfected to over-express PKC-beta1 or to inhibit its expression and then pretreated with low or high doses of EGF or a PKC activator, OAG (1-oleoyl-2-acetyl-sn-glycerol), before H(2)O(2). In N monolayers exposed to oxidant, pretreatment with EGF or PKC activators activated PKC-beta1, enhanced (45)Ca(2+) efflux, normalized Ca(2+), decreased monomeric G-actin, increased stable F-actin, and protected the cytoarchitecture of the actin. PKC inhibitors prevented these protective effects. Transfected cells stably over-expressing PKC-beta1 (+3.1-fold) but not N cell monolayers were protected from injury by even lower doses of EGF or OAG. EGF or OAG rapidly activated the over-expressed PKC-beta1. Antisense inhibition of PKC-beta1 expression (-90%) prevented all measures of EGF protection. Inhibitors of Ca(2+)-ATPase prevented EGF protection in N cells as well as protective synergism in transfected cells. EGF protects the assembly of the F-actin cytoskeleton in intestinal monolayers against oxidants in large part through the activation of PKC-beta1. EGF normalizes Ca(2+) by enhancing Ca(2+) efflux through PKC-beta1. We have identified novel biologic functions, protection of actin and Ca(2+) homeostasis, among the classical isoforms of PKC.
机译:使用肠单层,我们表明F-肌动蛋白细胞骨架稳定和Ca(2+)归一化有助于表皮生长因子(EGF)介导的抗氧化损伤的保护。然而,负责这些保护作用的细胞内介体仍然未知。由于蛋白激酶C-beta1(PKC-beta1)同工型在我们的幼稚(N)细胞中丰富,因此我们假设PKC-beta1对EGF的保护至关重要。将N Caco-2细胞单层暴露于H(2)O(2)+/- EGF,PKC或Ca(2+)调节剂。转染其他细胞以过表达PKC-beta1或抑制其表达,然后在H(2)之前用低剂量或高剂量EGF或PKC激活剂OAG(1-油酰基-2-乙酰基-sn-甘油)进行预处理。 O(2)。在暴露于氧化剂的N单层中,用EGF或PKC活化剂进行预处理可激活PKC-beta1,增强(45)Ca(2+)外排,标准化Ca(2+),减少单体G-肌动蛋白,增加稳定的F-肌动蛋白,并受到保护肌动蛋白的细胞结构。 PKC抑制剂阻止了这些保护作用。稳定地过表达PKC-beta1(+3.1倍),但没有N细胞单层的转染细胞受到更低剂量的EGF或OAG的保护,免受损伤。 EGF或OAG快速激活过度表达的PKC-beta1。对PKC-beta1表达的反义抑制(-90%)阻止了所有对EGF保护的措施。 Ca(2 +)-ATPase抑制剂可阻止N细胞中的EGF保护以及转染细胞中的保护性增效作用。 EGF在很大程度上通过激活PKC-beta1来保护肠道单层F-肌动蛋白细胞骨架的装配免受氧化剂的侵害。 EGF通过增强通过PKC-beta1的Ca(2+)外流归一化Ca(2+)。我们已经确定了新型的生物学功能,肌动蛋白和Ca(2+)稳态,PKC的经典同工型的保护。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号